US Stock Insider Trading | Cosmos Health Disclosed One Insider Trading Transaction on February 13

K-LinePoet · 2026-03-12T21:28:18+00:00

Cosmos Health disclosed on February 13, 2026, that Siokas Grigorios, a shareholder holding more than 10% of the company's shares, has been frequently buying the company's stock in recent times, with a total purchase of 388,500 shares, indicating optimism about the company's future and investment confidence. The company is a multinational pharmaceutical company focused on the import, export, and distribution of pharmaceuticals and health supplements.

K-LinePoet

2026-03-12 21:28:18

Abstract generation in progress

On February 13, 2026, Cosmos Health (COSM) disclosed one insider transaction. Shareholder holding more than 10%, Siokas Grigorios, purchased 385,000 shares on February 12, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 13, 2026	Shareholder >10%	Siokas Grigorios	February 12, 2026	Buy	385,000	0.37	145,000
February 12, 2026	Shareholder >10%	Siokas Grigorios	February 11, 2026	Buy	291,300	0.41	120,000
January 26, 2026	Shareholder >10%	Siokas Grigorios	January 23, 2026	Buy	90,300	0.50	45,000
January 21, 2026	Shareholder >10%	Siokas Grigorios	January 20, 2026	Buy	353,300	0.50	175,000
January 15, 2026	Shareholder >10%	Siokas Grigorios	January 14, 2026	Buy	493,500	0.45	220,000
January 13, 2026	Shareholder >10%	Siokas Grigorios	January 12, 2026	Buy	113,200	0.50	57,000
January 9, 2026	Shareholder >10%	Siokas Grigorios	January 8, 2026	Buy	156,200	0.52	81,000
January 8, 2026	Shareholder >10%	Siokas Grigorios	January 7, 2026	Buy	124,900	0.52	65,000
January 7, 2026	Shareholder >10%	Siokas Grigorios	January 6, 2026	Buy	134,000	0.54	72,000
December 22, 2025	Shareholder >10%	Siokas Grigorios	December 19, 2025	Buy	88,300	0.49	43,000

【Company Profile】

Cosmos Health, Inc. was incorporated in Nevada on July 21, 2009. The company is a multinational pharmaceutical company. It imports, exports, and distributes branded and generic drugs, OTC products, and various dietary and vitamin supplements through its established network. Its cross-border pharmaceutical operations serve wholesale distributors and independent retail pharmacies across the EU via a network of three strategic distribution centers and an additional warehouse facility. The company focuses on leveraging its growing purchasing power and supplier relationships to secure discounts and offer medicines at lower prices, continuing to organically grow its cross-border pharmaceutical wholesale business with attractive profit margins.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.